Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer stem cells, epithelial-mesenchymal transition, ATP and their roles in drug resistance in cancer
Haiyun Zhang, Alexander Steed, Milo Co, et al.
Cancer Drug Resistance (2021)
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Unveiling the mechanisms and challenges of cancer drug resistance
Sameer Ullah Khan, Kaneez Fatima, Shariqa Aisha, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 86
Cancer cell cycle heterogeneity as a critical determinant of therapeutic resistance
Ebrahim H. Maleki, Ahmad Reza Bahrami, Maryam Moghaddam Matin
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 189-204
Open Access | Times Cited: 57
Role of miRNA-145, 148, and 185 and Stem Cells in Prostate Cancer
Donatella Coradduzza, Sara Cruciani, Caterina Arru, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1626-1626
Open Access | Times Cited: 36
Cancer Stem Cells and the Tumor Microenvironment: Targeting the Critical Crosstalk through Nanocarrier Systems
Aadya Nayak, Neerada Meenakshi Warrier, Praveen Kumar
Stem Cell Reviews and Reports (2022) Vol. 18, Iss. 7, pp. 2209-2233
Open Access | Times Cited: 29
Tumor‐associated macrophages: A sentinel of innate immune system in tumor microenvironment gone haywire
Shaivy Malik, Niti Sureka, Sana Ahuja, et al.
Cell Biology International (2024) Vol. 48, Iss. 10, pp. 1406-1449
Closed Access | Times Cited: 6
Intricate relationship between cancer stemness, metastasis, and drug resistance
Tikam Chand Dakal, Ravi Bhushan, Caiming Xu, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 6
An emerging master inducer and regulator for epithelial-mesenchymal transition and tumor metastasis: extracellular and intracellular ATP and its molecular functions and therapeutic potential
Yanyang Cao, Eileen Chen, Xuan Wang, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 14
The Role and Therapeutic Targeting of CCR5 in Breast Cancer
Rasha Hamid, Mustafa Alaziz, Amanpreet S. Mahal, et al.
Cells (2023) Vol. 12, Iss. 18, pp. 2237-2237
Open Access | Times Cited: 13
Cancer Bioenergetics and Tumor Microenvironments—Enhancing Chemotherapeutics and Targeting Resistant Niches through Nanosystems
Aisha Farhana, Abdullah Alsrhani, Yusuf S. Khan, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3836-3836
Open Access | Times Cited: 12
p53-Dependent Cytoprotective Mechanisms behind Resistance to Chemo-Radiotherapeutic Agents Used in Cancer Treatment
Jayaraman Krishnaraj, Tatsuki Yamamoto, Rieko Ohki
Cancers (2023) Vol. 15, Iss. 13, pp. 3399-3399
Open Access | Times Cited: 11
Multidrug-resistant osteosarcoma: A systematic review
Mokhtar Ahmed Alsayed, Raad M. M. Althaqafi, Hashem Bukhary, et al.
Journal of Clinical Sciences (2025) Vol. 22, Iss. 1, pp. 42-50
Open Access
Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition
Jessica C. Hassel, Lisa Zimmer, Thomas Sickmann, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3448-3448
Open Access | Times Cited: 8
Impact of Non-Coding RNAs on Chemotherapeutic Resistance in Oral Cancer
Karen Yamaguchi, Tomofumi Yamamoto, Junichiro Chikuda, et al.
Biomolecules (2022) Vol. 12, Iss. 2, pp. 284-284
Open Access | Times Cited: 13
The role of LOXL2 induced by glucose metabolism-activated NF-κB in maintaining drug resistance through EMT and cancer stemness in gemcitabine-resistant PDAC
Yun Sun Lee, Hyung Sun Kim, Hyo Jung Kim, et al.
Journal of Molecular Medicine (2023) Vol. 101, Iss. 11, pp. 1449-1464
Open Access | Times Cited: 6
Phenanthroindolizidine Alkaloids Isolated from Tylophora ovata as Potent Inhibitors of Inflammation, Spheroid Growth, and Invasion of Triple-Negative Breast Cancer
Irene Reimche, Haiqian Yu, Ni Putu Ariantari, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10319-10319
Open Access | Times Cited: 10
Combinatory therapy of MRP1-targeted photoimmunotherapy and liposomal doxorubicin promotes the antitumor effect for chemoresistant small cell lung cancer
Fang Li, Chengqiong Mao, Stacy Yeh, et al.
International Journal of Pharmaceutics (2022) Vol. 625, pp. 122076-122076
Closed Access | Times Cited: 8
Cellular signaling in the hypoxic cancer microenvironment: Implications for drug resistance and therapeutic targeting
Hamid A. Bakshi, Michella Mkhael, Hakkim L. Faruck, et al.
Cellular Signalling (2023) Vol. 113, pp. 110911-110911
Open Access | Times Cited: 4
SOS2 modulates the threshold of EGFR signaling to regulate osimertinib efficacy and resistance in lung adenocarcinoma
Patricia L. Theard, Amanda J. Linke, Nancy E. Sealover, et al.
Molecular Oncology (2023) Vol. 18, Iss. 3, pp. 641-661
Open Access | Times Cited: 4
Cancer Stem Cells Niche Regulation Within the Tumor Microenvironment
Zainab Siddiqui, Zaffar Equbal, Naoshad Muhammad, et al.
Current Tissue Microenvironment Reports (2024)
Closed Access | Times Cited: 1
Cancer Stem Cells: Robust Features and Therapeutic Targets
Marwa M. Abu‐Serie, Eman Sarhan
Interdisciplinary cancer research (2024)
Closed Access | Times Cited: 1
Potentiation of novel porphyrin based photodynamic therapy against colon cancer with low dose doxorubicin and elucidating the molecular signalling pathways responsible for relapse
Ushasri Chilakamarthi, Namita S. Mahadik, Koteshwar Devulapally, et al.
Journal of Photochemistry and Photobiology B Biology (2022) Vol. 238, pp. 112625-112625
Closed Access | Times Cited: 6
SOS2 regulates the threshold of mutantEGFR-dependent oncogenesis
Patricia L. Theard, Amanda J. Linke, Nancy E. Sealover, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Purinergic approach to effective glioma treatment with temozolomide reveals enhanced anti-cancer effects mediated by P2X7 receptor
Bartosz Szymczak, Joanna Czarnecka, Sylwia Czach, et al.
Cellular Signalling (2023) Vol. 106, pp. 110641-110641
Closed Access | Times Cited: 3
Identification of NOX4 as a New Biomarker in Hepatocellular Carcinoma and Its Effect on Sorafenib Therapy
Hui-Zhou Li, Qingqing Liu, De‐Hua Chang, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2196-2196
Open Access | Times Cited: 2
Diverse temporal and spatial mechanisms work, partially through Stanniocalcin-1, V-ATPase and senescence, to activate the extracellular ATP-mediated drug resistance in human cancer cells
Haiyun Zhang, Jingwen Song, Ryan Ward, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Page 1 - Next Page

Scroll to top